- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.11. | Nexalin Technology, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.11. | (NXL) - Analyzing Nexalin Technology's Short Interest | 4 | Benzinga.com | ||
| 01.11. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 01.11. | Nexalin Technology, Inc.: Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th | 1 | GlobeNewswire (USA) | ||
| 01.11. | Nexalin erfüllt wieder Nasdaq-Anforderungen für Mindestangebotspreisregel | - | Investing.com Deutsch | ||
| 01.11. | Nexalin regains Nasdaq compliance with bid price rule | 1 | Investing.com | ||
| 01.11. | Nexalin Technology, Inc.: Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements | 62 | GlobeNewswire (Europe) | HOUSTON, TX, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market ("Nasdaq")... ► Artikel lesen | |
| 01.11. | LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 261 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / November 1, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. (Nasdaq:LOBO) and Nexalin Technology, Inc. (Nasdaq:NXL) on the RedChip Small Stocks... ► Artikel lesen | |
| 28.10. | Nexalin Technology, Inc.: Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease | 77 | GlobeNewswire (Europe) | HOUSTON, TX, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the "Company" or "Nexalin") today announced publication of a landmark study titled, "Altered Neuronal... ► Artikel lesen | |
| 28.10. | EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients | 3 | Benzinga.com | ||
| 25.10. | Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 184 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / October 25, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip Small... ► Artikel lesen | |
| 22.10. | Nexalin Technology, Inc.: Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA | 84 | GlobeNewswire (Europe) | Gen-3 Halo Headset Designed to Offer Convenient At-Home Treatment Through Virtual Clinic Model Study to Build on Positive Results from Previous Clinical Trial Treating Veterans with Mild Traumatic... ► Artikel lesen | |
| 17.10. | Nexalin Technology, Inc.: New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients | 2 | GlobeNewswire (USA) | ||
| 17.10. | EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study | 3 | Benzinga.com | ||
| 14.10. | Nexalin Technology, Inc.: Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs | 1 | GlobeNewswire (USA) | ||
| 19.09. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.09. | Nexalin Technology, Inc.: Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment | 1 | GlobeNewswire (USA) | ||
| 03.09. | Nexalin Technology shareholders approve board, plan amendment | 2 | Investing.com | ||
| 03.09. | Nexalin Technology, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.08. | Nexalin Technology, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings |
Seite:
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,325 | 0,00 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,310 | 0,00 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,160 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,310 | 0,00 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,070 | 0,00 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
| BIOMERICA | 0,320 | 0,00 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
| LIFEMD | 5,400 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| PROPHASE LABS | 0,690 | +0,73 % | ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript |
NEXALIN TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 3,810 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXALIN TECHNOLOGY INC finden Sie auf Wallstreet Online.
